Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Langston

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|October 8, 2005
AMA's program for the twenty-first centuryJ James Rohack, John H Armstrong, Duane M Cady, et al.
Journal of Biomedical Science|March 29, 2017
Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88Ann M Decker, Elaine A Gay, Kelly M Mathews, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of boneMicaela Rios Visconti, Anne L Langston, Nerea Alonso, et al.
Journal of Medicinal Chemistry|October 10, 2019
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric ModulatorsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
BMC Health Services Research|June 10, 2006
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?Anne L Langston, Marie Johnston, Clare Robertson, et al.
Journal of Medicinal Chemistry|June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor AgonistsDehui Zhang, David A Perrey, Ann M Decker, et al.
Neuropharmacology|March 8, 2017
Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulationStewart D Clark, Terrence P Kenakin, Steven Gertz, et al.
Bioorganic & Medicinal Chemistry|May 20, 2021
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybridsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
Lancet (London, England)|March 18, 2008
Prioritisation of routine vaccines: a mistake for the USAJon S Abramson, Jon R Almquist, Renée R Jenkins, et al.
ACS Chemical Neuroscience|July 25, 2017
Discovery of Novel Proline-Based Neuropeptide FF Receptor AntagonistsThuy Nguyen, Ann M Decker, Tiffany L Langston, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|October 8, 2005
AMA's program for the twenty-first centuryJ James Rohack, John H Armstrong, Duane M Cady, et al.
Journal of Biomedical Science|March 29, 2017
Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88Ann M Decker, Elaine A Gay, Kelly M Mathews, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of boneMicaela Rios Visconti, Anne L Langston, Nerea Alonso, et al.
Journal of Medicinal Chemistry|October 10, 2019
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric ModulatorsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
BMC Health Services Research|June 10, 2006
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?Anne L Langston, Marie Johnston, Clare Robertson, et al.
Journal of Medicinal Chemistry|June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor AgonistsDehui Zhang, David A Perrey, Ann M Decker, et al.
Neuropharmacology|March 8, 2017
Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulationStewart D Clark, Terrence P Kenakin, Steven Gertz, et al.
Bioorganic & Medicinal Chemistry|May 20, 2021
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybridsThuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
Lancet (London, England)|March 18, 2008
Prioritisation of routine vaccines: a mistake for the USAJon S Abramson, Jon R Almquist, Renée R Jenkins, et al.
ACS Chemical Neuroscience|July 25, 2017
Discovery of Novel Proline-Based Neuropeptide FF Receptor AntagonistsThuy Nguyen, Ann M Decker, Tiffany L Langston, et al.
Pageof 6